大行評級|傑富瑞:予美團“買入”評級 核心本地商業業務經營利潤穩健增長
傑富瑞發表研報指,美團宣佈發行總額25億美元的優先票據,其中包括12億美元於2028年到期的4.5釐優先票據及13億美元於2029年到期的4.625釐優先票據,考慮到美團有償款需求,今次並非完全出乎市場意料之外。該行又指,美團的核心本地商業(CLC)業務經營利潤持續錄得穩健增長,與其他業務亦產生協同效應,擁有較強的執行能力,管理層早前已上調CLC業務收入和經營利潤目標,因此仍給予“買入”評級,目標價為150港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.